Fungi: Friend or Foe? A Mycobiome Evaluation in Children With Autism and Gastrointestinal Symptoms

Jane Alookaran1, Yuying Liu1, Thomas A Auchtung2

  • 1Department of Pediatric Gastroenterology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX.

Insights

This study found that the presence of fungi, including Candida species, in the gut of children with autism spectrum disorder (ASD) is not significantly different from typically developing children and does not correlate with gastrointestinal symptoms.

Area of Science:

  • Microbiology
  • Pediatrics
  • Neurodevelopmental Disorders

Background:

  • Gastrointestinal (GI) symptoms are common in children with autism spectrum disorder (ASD) and are linked to alterations in the gut microbiome.
  • Limited research suggests a potential increase in Candida species in children with ASD, but evidence remains scarce.

Purpose of the Study:

  • To investigate the prevalence and abundance of fecal fungi, specifically Candida species, in children with ASD and GI symptoms compared to those with ASD but no GI symptoms and typically developing children.
  • To explore the association between fecal mycobiome composition, GI symptoms, behavioral symptoms, and markers of gut inflammation and fungal immunity in children with ASD.

Main Methods:

  • Fecal samples from children with ASD and GI symptoms (ASD + GI), ASD without GI symptoms (ASD - GI), and typically developing (TD) children were analyzed for fungal taxa using Internal Transcribed Spacer sequencing.
  • Evaluated GI symptom severity (GSI), behavioral symptoms (SRS-2), fecal calprotectin (inflammation marker), and serum dectin-1 (fungal immunity marker) via ELISA.

Main Results:

  • No significant differences were observed in the overall abundance of fungal species (alpha diversity) across the three groups.
  • Candida species were detected in 21% of ASD + GI, 56% of ASD - GI, and 25% of TD children, with no statistically significant difference between groups.
  • The presence of Candida species did not correlate with GI or behavioral symptoms, nor with fecal calprotectin or serum dectin-1 levels, indicating no increased fungal presence or immunity associated with ASD.

Conclusions:

  • Fungal presence in the stool of children with ASD appears to be at normal levels and is not associated with GI symptoms or gut inflammation.
  • These findings suggest that Candida overgrowth is unlikely to be a primary driver of GI issues in children with ASD.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
178
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
383
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
273